Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126680242 | 12668024 | 2 | F | 2015 | 20160906 | 20160819 | 20160916 | EXP | US-ELI_LILLY_AND_COMPANY-US201608006565 | ELI LILLY AND CO | 39.00 | YR | F | Y | 0.00000 | 20160916 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126680242 | 12668024 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | UNK, UNKNOWN | U | U | 20592 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126680242 | 12668024 | 1 | Bipolar disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126680242 | 12668024 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126680242 | 12668024 | Glucose tolerance impaired | |
126680242 | 12668024 | Leukaemia | |
126680242 | 12668024 | Renal disorder | |
126680242 | 12668024 | Weight decreased | |
126680242 | 12668024 | Weight increased | |
126680242 | 12668024 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |